DUALITYBIO-B(09606),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

09606 DUALITYBIO-B

Market Closed 04-17 16:08:09

200.000

+12.800

+6.84%

High204.400	Low182.400	Vol910.21K
Open182.400	D1 Closing187.200	Amplitude11.75%
Mkt Cap16.64B	Tradable Cap16.64B	Total Shares83.18M
T/O179.49M	T/O Rate1.09%	Tradable Shares83.18M
P/B-7.72	ROE--	EPS-139.61
52wk High222.000	52wk Low178.800	P/E-1.43
Dividend0.00	Div.Yield0.00	ROA-6.51%

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"DUALITYBIO-B","latestPrice":200,"timestamp":1744877289036,"preClose":187.2,"halted":0,"volume":910214,"delay":0,"floatShares":83175764,"shares":83175764,"eps":-139.6061314388193,"marketStatus":"Market Closed","change":12.8,"latestTime":"04-17 16:08:09","open":182.4,"high":204.4,"low":182.4,"amount":179488408,"amplitude":0.117521,"askPrice":200,"askSize":14600,"bidPrice":199,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-139.60614207108307,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745285400000},"marketStatusCode":7,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":187.2,"openAndCloseTimeList":[[1744853400000,1744862400000],[1744866000000,1744876800000]],"volumeRatio":0.13904653763376706,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09606","defaultTab":"news","newsList":[{"id":"2527636984","title":"Hong Kong Stocks Rise Slightly; Duality Biotherapeutics Soars 117% in Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2527636984","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527636984?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 16:44","pubTimestamp":1744706678,"startTime":"0","endTime":"0","summary":"Hong Kong stocks rose slightly on Tuesday as the US continued showing signs of flexibility in its tariff policy, while investors awaited China's GDP data.The Hang Seng Index climbed 0.23%, or 48.87 points, to end at 21,466.27. The Hang Seng China Enterprises Index rose 0.21%, or 17.07 points, to 7,982.88.After the exemption of smartphones and electronic items from its reciprocal tariffs, the Donald Trump-led US government is now considering a temporary waiver on cars from the levies, the SCMP reported.The US Commerce Department, however, is looking to probe the pharmaceutical and semiconductor industries, which could possibly lead to duties on the sectors, according to the same news report.Investors are also awaiting China's GDP data for the first quarter of 2025, which is expected to be released on Wednesday, April 16.GDP growth is expected to slow to 5.1% year over year in the first three months of 2025 from 5.4% in the quarter ended Dec. 31, 2024, according to Reuters-polled economi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["513600","HSI","MCHmain","HHImain","02833","09606"],"gpt_icon":1},{"id":"2527483099","title":"Duality Bio Shares Surge 91% in Hong Kong Debut, Defying Market Turmoil","url":"https://stock-news.laohu8.com/highlight/detail?id=2527483099","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527483099?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 11:26","pubTimestamp":1744687584,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics  made a stellar trading debut in Hong Kong on Tuesday morning as its shares soared over 91% at the opening bell, defying the stock market volatility caused by the tariff war between the world's two largest economies.The Chinese biotech firm opened at HK$181 per share, well above its initial public offering price of HK$94.60. As of 10:41 a.m., Hong Kong time, the stock traded at HK$209.60.The company's debut takes place against a backdrop of heightened uncertainty in global equity markets, driven by escalating US-China trade tensions.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["09606"],"gpt_icon":1},{"id":"2527085281","title":"China's Duality Biotherapeutics shares rise 130% in Hong Kong debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2527085281","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527085281?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 09:46","pubTimestamp":1744681580,"startTime":"0","endTime":"0","summary":"UPDATE 2-China's Duality Biotherapeutics shares rise 130% in Hong Kong debutAdds deal detail in third paragraph, analyst comments from sixth paragraphBy Scott Murdoch and Donny Kwok. \"It's also an indication that international investors are returning to China.\"Eleven cornerstone investors from both China and abroad subscribed to $65 million worth of Duality stock.The IPO also attracted strong interest from retail and institutional investors, Duality's filing showed, even at a time of global financial market turmoil.Retail investors applied for 115 times the shares on offer while the institutional portion was covered 13.5 times.\"Due to geopolitical conflict, investors are actually reassessing IPO prospects in the U.S. which means Hong Kong IPOs could be more popular in the future,\" said Criss Wang, an independent capital markets analyst.Hong Kong's Hang Seng Biotech Index .HSHKBIO is up 23.4% so far this year versus 6.76% for the Hang Seng Index.  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nL1N3QT01T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"gpt_icon":1},{"id":"1119833985","title":"Stock Track | Duality Biotherapeutics Skyrockets 114% in Hong Kong Stock Market Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1119833985","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119833985?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 09:32","pubTimestamp":1744680749,"startTime":"0","endTime":"0","summary":"Shares of Duality Biotherapeutics  soared an impressive 114.59% in their Hong Kong stock market debut on Tuesday, showcasing strong investor enthusiasm for the Chinese biotech company. The dramatic surge came as the stock opened at HK$181 per share, nearly double its initial public offering  price, and climbed further to HK$200 in early trading.The company's successful listing follows its recent global offering, which set the final offer price at HK$94.60 per share. Duality Biotherapeutics manag","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Duality Biotherapeutics Skyrockets 114% in Hong Kong Stock Market Debut","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09606"],"gpt_icon":0},{"id":"2527771081","title":"Shares of Duality Biotherapeutics  Rise to HK$200 Each in Hong Kong Debut VS Offer Price HK$94.60 Apiece","url":"https://stock-news.laohu8.com/highlight/detail?id=2527771081","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527771081?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 09:30","pubTimestamp":1744680641,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nL4N3QT02S:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09606"],"gpt_icon":0},{"id":"2527773241","title":"China's Duality Biotherapeutics shares set to rise 91% in Hong Kong debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2527773241","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527773241?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 09:20","pubTimestamp":1744680031,"startTime":"0","endTime":"0","summary":"China's Duality Biotherapeutics shares set to rise 91% in Hong Kong debutSYDNEY, April 15  - Shares of China's Duality Biotherapeutics 9606.HK were set to rise 91.3% in their Hong Kong debut on Tuesday after the company raised $213 million in an initial public offering launched as financial markets reacted savagely to the U.S tariffs package.   ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nL4N3QT02S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"gpt_icon":1},{"id":"2527729761","title":"Shares of Duality Biotherapeutics  Set to Open at HK$181 Each in Hong Kong Debut VS Offer Price HK$94.60 Apiece","url":"https://stock-news.laohu8.com/highlight/detail?id=2527729761","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527729761?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 09:20","pubTimestamp":1744680031,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nL4N3QT02S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09606"],"gpt_icon":0},{"id":"2527192850","title":"Duality Biotherapeutics Says Final Offer Price Under Global Offering HK$94.60 Per Offer Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2527192850","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527192850?lang=en_us&edition=full_marsco","pubTime":"2025-04-14 23:44","pubTimestamp":1744645495,"startTime":"0","endTime":"0","summary":"April 14 (Reuters) - Duality Biotherapeutics Inc <9606.HK>::*FINAL OFFER PRICE UNDER GLOBAL OFFERING HK$94.60 PER OFFER SHARE*Further company coverage: 9606.HK* ((Reuters.Briefs@thomsonreuters.com;)) ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nRSD9JF6MG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"gpt_icon":0},{"id":"2527167074","title":"Duality Biotherapeutics - Final Offer Price Under Global Offering HK$94.60 per Offer Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2527167074","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527167074?lang=en_us&edition=full_marsco","pubTime":"2025-04-14 22:10","pubTimestamp":1744639825,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QQ089:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09606"],"gpt_icon":0},{"id":"2525973052","title":"Duality Biotherapeutics Braves Markets, Launches HK$1.6 Billion Hong Kong IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2525973052","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525973052?lang=en_us&edition=full_marsco","pubTime":"2025-04-07 12:43","pubTimestamp":1744000998,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics  launched its initial public offering in Hong Kong on Monday, braving the global stock market rout triggered by US President Donald Trump's reciprocal tariffs.The Chinese biotech firm is offering 15,071,600 shares at between HK$94.60 and HK$103.20 apiece, a deal that could raise as much as HK$1.56 billion if priced at the upper limit of the range.Of the total shares on offer, 1.5 million are earmarked for Hong Kong investors. If there is a strong demand for the IPO, an over-allotment option of up to 2.26 million shares can be exercised.The developer of antibody drug conjugates secured Germany's BioNTech and 10 private equity funds as cornerstone investors. They pledged to subscribe to $65 million worth of IPO shares.Duality Bio expects to determine the listing price on April 11 and disclose the allocations on April 14. It intends to start trading on the Hong Kong bourse on April 15.Listing proceeds will be used for the research, development, and commercializatio","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["09606"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dualitybiologics.com","stockEarnings":[{"period":"1week","weight":1.1142},{"period":"ytd","weight":1.1142}],"compareEarnings":[{"period":"1week","weight":0.0345},{"period":"1month","weight":-0.1352},{"period":"3month","weight":0.0925},{"period":"6month","weight":0.0284},{"period":"1year","weight":0.3165},{"period":"ytd","weight":0.0666}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Yingen Biotech is an innovative clinical-stage biopharmaceutical company focused on developing next-generation antibody-conjugated drugs (ADCs) for patients with cancer and autoimmune diseases. The company has successfully built several next-generation ADC technology platforms with global intellectual property rights. Based on in-depth research and exploration of the biological mechanisms of diseases, Yingen Biotech has a rich clinical ADC research and development pipeline, and has carried out multiple global multi-center clinical trials in more than 17 countries, enrolling more than 2,000 patients. At the same time, Yingen Biotech has reached a number of overseas licensing agreements with global pharmaceutical companies and top innovative pharmaceutical companies. As a global ADC innovation engine, Yingen Biotech continues to develop the next generation of novel ADCs, including dual-antibody ADCs, novel mechanism-loaded ADCs, and self-exempt ADCs.","exchange":"SEHK","name":"DUALITYBIO-B","nameEN":"DUALITYBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"DUALITYBIO-B(09606),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest DUALITYBIO-B(09606) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"DUALITYBIO-B,09606,DUALITYBIO-B股票,DUALITYBIO-B股票老虎,DUALITYBIO-B股票老虎国际,DUALITYBIO-B行情,DUALITYBIO-B股票行情,DUALITYBIO-B股价,DUALITYBIO-B股市,DUALITYBIO-B股票价格,DUALITYBIO-B股票交易,DUALITYBIO-B股票购买,DUALITYBIO-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"DUALITYBIO-B(09606),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest DUALITYBIO-B(09606) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}